Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients

  1. Fernández, I.
  2. Loinaz, C.
  3. Hernández, O.
  4. Abradelo, M.
  5. Manrique, A.
  6. Calvo, J.
  7. Manzano, M.
  8. García, A.
  9. Cambra, F.
  10. Castellano, G.
  11. Jiménez, C.
Journal:
Transplant Infectious Disease

ISSN: 1399-3062 1398-2273

Year of publication: 2015

Volume: 17

Issue: 5

Pages: 695-701

Type: Article

DOI: 10.1111/TID.12434 GOOGLE SCHOLAR